CAS RN 152459-95-5
Imatinib, Mikromol™
Discover Mikromol – din pålitliga källa för högkvalitativa läkemedelsreferensstandarder. Stöder noggrann, regelrätt analys med material som är ackrediterat 17034 ISO och utformat för att säkerställa förtroende för varje resultat.
Imatinib, TRC
CAS: 152459-95-5 Molekylformel: C29 H31 N7 O Molekylvikt (g/mol): 493.6 Synonym: Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide,CGP 57148,Genfatinib,Imatinib IUPAC-namn: 4-[(4-metylpiperazin-1-yl)metyl]-N-[4-metyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]fenyl]bensamid LEDER: CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
Imatinib, MedChemExpress
MedChemExpress Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.